Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

INVO Fertility (IVF) EBITDA Margin (2016 - 2025)

INVO Fertility (IVF) has disclosed EBITDA Margin for 15 consecutive years, with 91.29% as the latest value for Q3 2025.

  • Quarterly EBITDA Margin fell 238.0% to 91.29% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 271.63% through Sep 2025, down 17409.0% year-over-year, with the annual reading at 27.68% for FY2024, 19370.0% up from the prior year.
  • EBITDA Margin for Q3 2025 was 91.29% at INVO Fertility, up from 158.76% in the prior quarter.
  • The five-year high for EBITDA Margin was 2058.28% in Q4 2022, with the low at 1820.37% in Q2 2022.
  • Average EBITDA Margin over 5 years is 390.62%, with a median of 158.76% recorded in 2025.
  • The sharpest move saw EBITDA Margin soared 191500bps in 2022, then tumbled -216593bps in 2023.
  • Over 5 years, EBITDA Margin stood at 143.29% in 2021, then soared by 1336bps to 2058.28% in 2022, then crashed by -105bps to 107.65% in 2023, then surged by 253bps to 164.81% in 2024, then crashed by -155bps to 91.29% in 2025.
  • According to Business Quant data, EBITDA Margin over the past three periods came in at 91.29%, 158.76%, and 1043.09% for Q3 2025, Q2 2025, and Q1 2025 respectively.